QI
BHVN

QS Investors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

QS Investors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,600
Closed -$235K – 1295
2020
Q3 		$235K Sell
3,600
-15,000
-81% -$983K ﹤0.01% 1021
2020
Q2 		$1.36M Hold
18,600
– – 0.02% 633
2020
Q1 		$633K Hold
18,600
– – 0.01% 785
2019
Q4 		$1.01M Hold
18,600
– – 0.01% 776
2019
Q3 		$776K Hold
18,600
– – 0.01% 839
2019
Q2 		$814K Buy
+18,600
New +$1.05M 0.01% 856

Other funds holding BHVN

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QS Investors's BHVN Position: Q4 2020 in Review

QS Investors sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2020, closing a stake of 3,600 shares — an estimated $235K sold.

QS Investors first reported a position in BHVN in Q2 2019 and held it in 6 quarters. The position peaked at $1.36M in Q2 2020. 238 funds tracked by Wall St. Rank hold BHVN as of Q4 2020.

  • QS Investors reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2020 after selling out during the quarter.
  • QS Investors sold 3,600 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2020, an estimated $235K.
  • QS Investors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 6 quarters.
  • QS Investors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.36M in Q2 2020.
  • 238 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2020.

Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.